ciprofloxacin has been researched along with Lupus Erythematosus, Cutaneous in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Newman, AJ | 1 |
Mullens, D | 1 |
Lin, CC | 1 |
Barr, J | 1 |
1 other study available for ciprofloxacin and Lupus Erythematosus, Cutaneous
Article | Year |
---|---|
Subacute cutaneous lupus erythematosus observed with ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Pro | 2018 |